[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356855-105":59,"doc-detail-356855-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-phosphoproteomic-analysis-reveals-co-regulatory-phosphorylation-networks-of-rhotekin-in-cancer-progression","Integrative phosphoproteomic analysis reveals co-regulatory phosphorylation networks of rhotekin in cancer progression","","Rhotekin (RTKN), a Rho GTPase effector, drives malignancy by enhancing proliferation and migration while suppressing apoptosis, yet its phosphoregulatory network is poorly defined. This study systematically retrieved PubMed-indexed, MeSH-guided phosphoproteomics datasets to map RTKN-associated phosphorylation dynamics. Analysis of 618 quantitative and 179 differential datasets identified 27 Class-I phosphosites and five consistently observed sites, located in accessible regions of an AlphaFold2 model. Co-regulation profiling linked predominant RTKN phosphosites with apoptosis, cell growth, motility, and cytoskeletal remodeling, and suggested TRPM7 and PAK4 as upstream kinases, supporting RTKN phosphosite-specific cancer research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-phosphoproteomic-analysis-reveals-co-regulatory-phosphorylation-networks-of-rhotekin-in-cancer-progression/356855/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-phosphoproteomic-analysis-reveals-co-regulatory-phosphorylation-networks-of-rhotekin-in-cancer-progression/356855.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of this integrative phosphoproteomic study on rhotekin?","Question",{"text":112,"@type":113},"To characterize RTKN-associated phosphorylation dynamics by integrating large-scale cellular phosphoproteomics datasets and identifying functional phosphosites and their co-regulatory network context.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many Class-I RTKN phosphosites were identified, and which sites were consistently observed?",{"text":117,"@type":113},"The analysis identified 27 Class-I phosphosites in RTKN, with five sites—Ser106, Ser220, Ser520, Ser529, and Ser543—consistently observed across multiple datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"Which predicted upstream kinases and co-regulated pathways were highlighted?",{"text":121,"@type":113},"TRPM7 and PAK4 were identified as predicted upstream kinases phosphorylating RTKN at Ser220 and Ser520. Pathway analysis indicated that co-regulated proteins relate to cancer-associated signaling and processes such as apoptosis, growth, motility, and cytoskeletal reorganization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356855,1790535028,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Palollathil et al. Discover Oncology (2026) 17:778 [https://doi.org/10.1007/s12672-026-04982-6](https://doi.org/10.1007/s12672-026-04982-6)  \nDiscover Oncology  \nANALYSIS Open Access  \nIntegrative phosphoproteomic analysis reveals  co-regulatory phosphorylation networks of rhotekin in cancer progression  \nAkhina Palollathil1*, Althaf Mahin1, Athira Perunelly Gopalakrishnan1, Alimath Sambreena1, Samseera Ummar 1, Prathik Basthikoppa Shivamurthy1, R. Ganesan2, Manavalan Vijayakumar3 and Rajesh Raju 1*  \n*Correspondence:  \nAkhina Palollathil[akhinap.ciods@yenepoya.edu.in](akhinap.ciods@yenepoya.edu.in)[ ](akhinap.ciods@yenepoya.edu.in)Rajesh Raju [rajeshraju@yenepoya.edu.in](rajeshraju@yenepoya.edu.in)[ ](rajeshraju@yenepoya.edu.in)1Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, Karnataka 575018, India 2School of Computer Science and Engineering, Vellore Institute of Technology, Chennai,  \nTamil Nadu 600127, India 3Department of Surgical Oncology, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore,  \nKarnataka 575018, India  \nAbstract  \nRhotekin (RTKN), a Rho GTPase effector, promotes the development of malignancies, including breast, gastric, and colon cancers, by enhancing cell proliferation and migration while inhibiting apoptosis. Despite its oncogenic role, the phosphoregulatory network of RTKN remains largely unexplored, with no experimental evidence on its upstream kinases and functional phosphosites. To characterize RTKN-associated phosphorylation dynamics, PubMed-indexed studies were systematically retrieved using predefined MeSH terms to compile largescale cellular phosphoproteomics datasets. Analysis of 618 quantitative profiling and 179 differential abundance datasets identified 27 Class-I phosphosites in RTKN. Among these, five sites-Ser106, Ser220, Ser520, Ser529, and Ser543 were consistently observed across multiple datasets, suggesting them as predominant sites with potential functional significance. Structural mapping of predominant sites onto the AlphaFold2-predicted model indicated that these sites are located in accessible regions, highlighting their potential susceptibility to kinasemediated regulation. As these sites represent understudied phosphosites, a robust strategy was employed to identify their functional role by assessing co-regulated phosphosites on other proteins (PsOPs) . ACIN1_Ser243, CTNNA1_Ser641, and SHROOM2_Ser1036 were among the top positively co-regulated PsOPs, whereas MICALL1_Ser644, PRP4K_Ser366, and MYO18A_Ser1970 were negatively coregulated. PsOPs were mainly involved in apoptosis, cell growth, motility, and cytoskeletal reorganization, suggesting potential functional convergence with RTKN.  \nAdditionally, phosphorylation at RTKN Ser520 and Ser543 co-occurred across multiple datasets. Moreover, TRPM7 and PAK4 were identified as predicted upstream kinases phosphorylating RTKN at Ser220 and Ser520 . Pathway analysis showed involvement of co-regulated proteins in cancer-associated signaling pathways. These findings provide a foundation for future research to elucidate the phosphosite-specific role of RTKN in cancer.  \nKeywords Post-translational modifications, Cancer, Nervous system, Phosphorylation, Mass spectrometry, Phosphoproteomics  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a","cbCaibPCUTSIa3W9","https://ap.wps.com/l/cbCaibPCUTSIa3W9","pdf",5715346,27,"English","# Abstract\n# Introduction\n## Rhotekin structure and functional roles\n## RTKN regulation by phosphorylation and upstream kinases","[{\"question\":\"What is the main aim of this integrative phosphoproteomic study on rhotekin?\",\"answer\":\"To characterize RTKN-associated phosphorylation dynamics by integrating large-scale cellular phosphoproteomics datasets and identifying functional phosphosites and their co-regulatory network context.\"},{\"question\":\"How many Class-I RTKN phosphosites were identified, and which sites were consistently observed?\",\"answer\":\"The analysis identified 27 Class-I phosphosites in RTKN, with five sites—Ser106, Ser220, Ser520, Ser529, and Ser543—consistently observed across multiple datasets.\"},{\"question\":\"Which predicted upstream kinases and co-regulated pathways were highlighted?\",\"answer\":\"TRPM7 and PAK4 were identified as predicted upstream kinases phosphorylating RTKN at Ser220 and Ser520. Pathway analysis indicated that co-regulated proteins relate to cancer-associated signaling and processes such as apoptosis, growth, motility, and cytoskeletal reorganization.\"}]","Integrative phosphoproteomic analysis reveals co-regulatory phosphorylation networks of rhotekin in cancer progression | PDF",1790127694,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0f876f4b207b8d02e0ffccbb440ef88.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15e13548808f632c92d3f2d7bfc7fe03.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9ec6b13fd09a7dbacb8ad17331ce38f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21bc78cf803d56dc956bb38bda37234a.webp",980,1306]